CDC-RFA-GH21-2158: Strengthening Urban Health Services and Models of Care in Kampala Capital City Authority (KCCA)- Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR)
Closed
This grant is closed. A newer notice from the same program is forecast: Capacity Building for National Immunization Programs in the Eastern Mediterranean Region (CDC-RFA-JG-27-0070). Status: Expected deadline February 12, 2027. It is in our archive of Centers for Disease Control - CGH notices from 2021.
Centers for Disease Control - CGH offered grants to the applicants described in the notice. It expected to make one award. Applications closed on May 4, 2021.
From the official notice on Grants.gov, last changed March 25, 2021. Checked November 7, 2026.
- Expected awards1
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | March 3, 2021 |
|---|---|
| Deadline | May 4, 2021 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants that can apply for this NOFO are:Kampala Capital City Authority (KCCA), Uganda
Is this a realistic fit?
- Most of the money in the 2 programs behind this notice (60% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $2,000,000 for Year 1, subject to the availability of funds. This NOFO will support the following strategies:Strategy 1. Partnerships and Governance: Collaboration for harmonized and integrated annual health work plans, monitoring and evaluation (M&E) plans, economic analyses, management of US government (USG) and other donor funds, health information and laboratory systems that strengthen HIV, TB, other reportable infectious and non-infectious diseases that impact people living with HIV (PLHIV) and populations affected by HIV and TB.Strategy 2. Ensure HIV and TB service delivery: Strengthening capacity to perform public health functions to achieve HIV and TB epidemic control in KCCA and its metropolitan area. The recipient will strengthen collaboration between the public and private sector. Strategy 3. Integration of HIV and TB with other diseases : Interventions to protect PLHIV and persons affected by HIV and TB from epidemics through activities including outbreak detection, investigation, and response, strengthening laboratory systems, surveillance for priority diseases and antimicrobial resistance (AMR) detection and control. Strategy 4. Health information systems integration for surveillance, M&E, and laboratory systems strengthening: Supporting surveillance and laboratory monitoring systems for HIV and TB, and other disease priorities; and building epidemiologic capacity to prevent, detect, and respond to disease threats through analysis of routine data and special surveys.
Who has won Global AIDS grants before
From fiscal 2021 to 2025, Global AIDS (93.067) awarded $7.6 billion across 521 grant awards, an average of $14.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Trustees of Columbia University in the City of New York | New York | 32 | $684 million |
| Elizabeth Glaser Pediatric AIDS Foundation | District of Columbia | 13 | $387 million |
| Management and Development for Health | 5 | $282 million | |
| Apin Public Health Initiatives LTD/Gte | 4 | $209 million | |
| University of Washington | Washington | 8 | $195 million |
Who has won Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security grants before
From fiscal 2021 to 2025, Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security (93.318) awarded $1.3 billion across 306 grant awards, an average of $4.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| African Field Epidemiology Network LTD | 6 | $147 million | |
| The Task Force for Global Health, Inc. | Georgia | 7 | $138 million |
| World Health Organization, Somalia | 14 | $125 million | |
| Association of Public Health Laboratories, Inc. (the) | Maryland | 3 | $61.5 million |
| The Johns Hopkins University | Maryland | 5 | $42.7 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, CDC-RFA-JG-27-0070, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-GH21-2158 still open?
No. It closed on May 4, 2021. A newer notice is forecast: CDC-RFA-JG-27-0070, expected deadline February 12, 2027.
Who can apply for Strengthening Urban Health Services and Models of Care in Kampala Capital City Authority (KCCA)- Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR)?
Centers for Disease Control - CGH accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Strengthening Urban Health Services and Models of Care in Kampala Capital City Authority (KCCA)- Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR)?
Closed May 4, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has won Global AIDS grants before?
The largest recipients over five fiscal years were The Trustees of Columbia University in the City of New York, Elizabeth Glaser Pediatric AIDS Foundation, Management and Development for Health. The program made 521 awards worth $7.6 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)